BLISS-BELIEVE study on sequential belimumab and rituximab in SLE reports mixed results but promising disease control benefits
The phase 3 BLISS-BELIEVE trial provided valuable insights into the efficacy and safety of sequential
The phase 3 BLISS-BELIEVE trial provided valuable insights into the efficacy and safety of sequential
A recent study published in The Journal of Nutritional Biochemistry shed light on the role of
The FOREMOST trial results published in the Annals of the Rheumatic Diseases demonstrated the potential
A recent study published in Human Molecular Genetics has spotlighted E74-like factor 1 (ELF1) as
In a significant development for rheumatoid arthritis (RA) management, interim results from the long-term FINCH
Dr. Sampath Rangasamy spoke about the role of inflammation in microvascular diabetic complications.
Dr. K. Gokulakrishnan discussed the adipose tissue and brain – The neuroinflammatory link. Neuroinflammation
Dr. Chandrashekara. S discussed the Immune-Mechanism of Autoimmune related Inflammatory Diseases of Skin. Skin
Autoimmune-mediated inflammatory skin disorder- introduction to clinical variety was discussed by Dr. Shekhar Neema.
Dr. Jyotirmay Biswas spoke about autoimmune uveitis and scleritis. 50% and 90% of uveitis and
Dr. Padmamalini discussed the clinical clues in the differential diagnosis of anterior uveitis.
Clinical evaluation of episcleritis & scleritis and interpretation of the differential diagnosis of episcleritis
Dr. Prarthana Bhandary spoke about the ophthalmological perspective of dry eye differential diagnosis and
Dr. Shilpa discussed briefly ocular surface inflammation including the different conditions i.e., Dry eye disease,
Rheumatology and Ophthalmology interactive series Inflammatory disease of the eye- Introduction Ocular surface inflammation- introduction